ArticleCPT: pharmacometrics & systems pharmacology2024

Isatuximab-dexamethasone-pomalidomide combination effects on serum M protein and PFS in myeloma: Development of a joint model using phase I/II data.

Antoine Pitoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.